ARCHIVES

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

This article is from The Cancer Letter archive.

Vol. 33 No. 17 | May 4, 2007

Download PDF Visit The Full Archive

Related Articles

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

Task Force Members Give Mea Culpa at Congressional Hearing

December 4, 2009

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979